Ixcells Biotechnologies Secures Strategic Growth Investment From Great Point Partners
09/29/22, 2:04 PM
Location
san diegoIndustry
therapeutics
biotechnology
iXCells Biotechnologies (“iXCells” or the “Company”), a high growth provider of cell-based products and discovery services to the academic, biotech and pharmaceutical communities worldwide, with special focus on primary and induced pluripotent stem cell (“iPSC”) derived cellular models, today announced receiving a growth investment from Connecticut-based Great Point Partners (“GPP”), a private investment firm focusing on the healthcare industry.
Company Info
Location
trade street
san diego, california, united states
Additional Info
Founded in 2014 and based in San Diego, CA, iXCells Biotechnologies is an innovative cell biology and cell technology company that provides preclinical drug discovery solutions with the focus on disease relevant cellular models enabling technologies and services to the academic, biotech and pharma communities to accelerate the pace of drug discovery. iXCells offers customers access to high quality primary and iPSC derived cells, custom iPSC services, functional bioassay development and drug screening. To learn more about this innovative leader within the preclinical iPSC sector, visit http://www.ixcellsbiotech.com.